Frontier Medicines
Biotechnology, 151 Oyster Point BLVD Fl 2, South San Francisco, California, 94080, United States, 51-200 Employees
Phone Number: 65********
Who is FRONTIER MEDICINES
Frontier Medicines, located in South San Francisco, CA and Boston, MA, is a precision medicine company that has pioneered a powerful discovery and development platform designed to generat...
Read More
-
Headquarters: 151 Oyster Point BLVD Fl 2, South San Francisco, California, 94080, United States
-
Date Founded: 2018
-
Employees: 51-200
-
Revenue: $10 Million to $25 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 7389
Does something look wrong? Fix it. | View contact records from FRONTIER MEDICINES
Frontier Medicines Org Chart and Mapping
Email
Phone
Similar Companies to Frontier Medicines
Denali Therapeutics
-
201-500
-
$ 250 Million to 500 Million
Genentech
-
10001+
-
$ 1 Billion and Over
IDEAYA Biosciences
-
51-200
-
$ 25 Million to 50 Million
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Frontier Medicines
Answer: Frontier Medicines's headquarters are located at 151 Oyster Point BLVD Fl 2, South San Francisco, California, 94080, United States
Answer: Frontier Medicines's phone number is 65********
Answer: Frontier Medicines's official website is https://frontiermeds.com
Answer: Frontier Medicines's revenue is $10 Million to $25 Million
Answer: Frontier Medicines's SIC: 7389
Answer: Frontier Medicines has 51-200 employees
Answer: Frontier Medicines is in Biotechnology
Answer: Frontier Medicines top competitors include: Denali Therapeutics , Genentech , IDEAYA Biosciences
Answer: Frontier Medicines contact info: Phone number: 65******** Website: https://frontiermeds.com
Answer: Frontier Medicines, located in South San Francisco, CA and Boston, MA, is a precision medicine company that has pioneered a powerful discovery and development platform designed to generate medicines against disease-causing proteins previously considered undruggable. We are deploying our technologies in chemoproteomics, covalent drug discovery, and machine learning to develop a pipeline of groundbreaking medicines against the most important drivers of disease. Our lead program targets both the activated and inactive forms of KRAS G12C, a validated driver in a number of cancers that until recently has been undruggable. Our pipeline embodies our vision of bolding advancing science to defeat disease, starting with cancer.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month